§
Luxuse
Patent Intelligence
Sign In
← Back to Patent Explorer
US5931779A Expired / Lapsed US ⏱️ 0.0 years remaining

Real-time in-vivo measurement of myoglobin oxygen saturation

Assignee: University of Washington
•
Filing: 1997-06-06
•
Granted: 1999-08-03
•
Expires: 2017-06-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for determining myoglobin oxygen fractional saturation in vivo in muscle tissue and intracellular oxygen tension (pO2), typically in the presence of hemoglobin, is provided. The method comprises measuring the absorption spectrum of the tissue using spectrographic equipment known to the art, including equipment for non-invasively taking spectroscopic measurements of tissue, or adaptations of such equipment to provide the preferred measurements described herein, or using spectrographic equipment specifically designed as described herein for use in non-invasive measurements of reflectance spectra. The measured spectrum is corrected for light scattering effects, such as by taking the second derivative of the data, or by using other means which are known to the art. Myoglobin fractional oxygen saturation is calculated from the measured spectrum employing calibration coefficients that are themselves calculated from application of multivariate analysis to a calibration set created from the second derivatives of absorption spectra. The calibration set spectra preferably representing absorbances of (1) a range of concentrations of hemoglobin (wherein a range of concentrations of oxyhemoglobin and deoxyhemoglobin are present), (2) one concentration of myoglobin (preferably selected to match the concentration of myoglobin in the target muscle tissue) with varying relative amounts of oxy- and deoxymyoglobin and (3) a range of concentrations of scattering agents to mimic scattering encountered in target tissue. The range of concentrations of oxy- and deoxyhemoglobin and the relative amounts of oxy- and deoxymyoglobin represented in calibration set spectra span the range of concentrations of these species encountered in the target tissue. Sample tissue spectra are preferably measured in the visible, the near-infrared or both wavelength ranges. Diffuse reflectance spectroscopy is the preferred method for obtaining spectral data. A partial least squares (PLS) method is preferably used to calculate calibration coefficients from the calibration set which in turn are used to calculate myoglobin oxygen saturation from the measured data. Other means known to the art may also be used. Measured myoglobin oxygen saturation determinations can be used to calculate intracellular oxygen tension, if accurate p50 values at appropriate physiologic pH and temperature for myoglobin-oxygen dissociation are available. An improved method of accurate determination of myoglobin-oxygen dissociation curves under physiologically relevant conditions is also provided.

Inventors

  • 👤 Lorilee S. Arakaki
  • 👤 Eric Feigl
  • 👤 Martin J. Kushmerick
  • 👤 David Marble
  • 👤 David H. Burns
  • 👤 Kenneth H. Schenkman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 23:16
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/145; A61B5/1455; A61B5/1459

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 78 words
A method for determining myoglobin fractional oxygen saturation in vivo in muscle tissue which comprises the steps of: (a) measuring an absorption spectrum of a muscle tissue in vivo, (b) calculating the myoglobin fractional oxygen saturation of said tissue from said measured absorption spectrum using calibration coefficients determined from multivariate analysis employing a calibration set comprising in vitro absorbance spectra wherein in the spectra of said calibration set myoglobin and hemoglobin saturation are varied independently of one another.
Claim 2
Independent Claim 78 words
A method for determining myoglobin fractional oxygen saturation in vivo in muscle tissue which comprises the steps of: (a) measuring an absorption spectrum of a muscle tissue in vivo, (b) calculating the myoglobin fractional oxygen saturation of said tissue from said measured absorption spectrum using calibration coefficients determined from multivariate analysis employing a calibration set comprising in vitro absorbance spectra wherein in the spectra of said calibration set myoglobin and hemoglobin saturation are varied independently of one another.
Claim 3
Dependent Claim 36 words
The method of claim 1 wherein in step (a) a derivative of said spectrum is taken prior to step (b) and wherein in step (b) said calibration set comprises derivatives of said in vitro absorbance spectra.
Claim 4
Dependent Claim 35 words
The method of claim 1 wherein in step (a) second-derivative of said spectrum is taken prior to step (b) and wherein in step (b) said calibration set comprises second-derivatives of said in vitro absorbance spectra.
Claim 5
Dependent Claim 13 words
The method of claim 1 wherein said muscle tissue is blood-perfused muscle tissue.
Claim 6
Dependent Claim 18 words
The method of claim 1 wherein said absorption spectrum is measured in the visible or near-infrared wavelength region.
Claim 7
Dependent Claim 15 words
The method of claim 1 wherein said absorption spectrum is measured using diffuse reflectance spectroscopy.
Claim 8
Dependent Claim 16 words
The method of claim 6 wherein said absorption spectrum is measured in the near-infrared wavelength region.
Claim 9
Dependent Claim 16 words
The method of claim 6 wherein said absorption spectrum is measured in the visible wavelength region.
Claim 10
Dependent Claim 24 words
The method of claim 6 wherein a reflectance spectrum is obtained employing a fiber optic contact probe comprising spatially separated illuminating and detection fibers.
Claim 11
Dependent Claim 29 words
The method of claim 9 wherein the minimal spacing between the illuminating and detection fibers in said fiber optic probe is between about 1 mm to about 3 mm.
Claim 12
Dependent Claim 15 words
The method of claim 1 wherein said multivariate analysis is a partial least squares analysis.
Claim 13
Dependent Claim 17 words
The method of claim 1 wherein a scattering agent is represented in spectra of said calibration set.
Claim 14
Independent Claim 131 words
A method for determining intracellular oxygen tension in vivo in muscle tissue which comprises the steps of: (a) determining the myoglobin fractional oxygen saturation of said muscle tissue in vivo by: (i) measuring an absorption spectrum of a muscle tissue in vivo, and taking a derivative of said spectrum; (ii) calculating the myoglobin fractional oxygen saturation of said tissue from said measured absorption spectrum using calibration coefficients determined from multivariate analysis employing a calibration set comprising derivatives in vitro absorbance spectra wherein in the spectra of said calibration set myoglobin and hemoglobin saturation are varied independently of one another; and (b) calculating the intracellular oxygen tension of said muscle tissue from the oxygen saturation data of step(a) employing a p50 value obtained from an optical spectroscopic determination of myoglobin-oxygen dissociation curves.
Claim 15
Independent Claim 131 words
A method for determining intracellular oxygen tension in vivo in muscle tissue which comprises the steps of: (a) determining the myoglobin fractional oxygen saturation of said muscle tissue in vivo by: (i) measuring an absorption spectrum of a muscle tissue in vivo, and taking a derivative of said spectrum; (ii) calculating the myoglobin fractional oxygen saturation of said tissue from said measured absorption spectrum using calibration coefficients determined from multivariate analysis employing a calibration set comprising derivatives in vitro absorbance spectra wherein in the spectra of said calibration set myoglobin and hemoglobin saturation are varied independently of one another; and (b) calculating the intracellular oxygen tension of said muscle tissue from the oxygen saturation data of step(a) employing a p50 value obtained from an optical spectroscopic determination of myoglobin-oxygen dissociation curves.
Claim 16
Dependent Claim 36 words
The method of claim 13 wherein in step (a) a derivative of said spectrum is taken prior to step (b) and wherein in step (b) said calibration set comprises derivatives of said in vitro absorbance spectra.
Claim 17
Dependent Claim 35 words
The method of claim 13 wherein in step (a) second-derivative of said spectrum is taken prior to step (b) and wherein in step (b) said calibration set comprises second-derivatives of said in vitro absorbance spectra.
Claim 18
Dependent Claim 16 words
The method of claim 13 wherein said myoglobin-oxygen dissociation curves are determined using multiwavelength spectroscopic analysis.
Claim 19
Dependent Claim 22 words
The method of claim 16 wherein said myoglobin-oxygen dissociation curves are determined by a method which compensates for the presence of metmyoglobin.
Claim 20
Dependent Claim 13 words
The method of claim 13, wherein said muscle tissue is blood-perfused muscle tissue.
Claim 21
Dependent Claim 18 words
The method of claim 13 wherein said absorption spectrum is measured in the visible or near-infrared wavelength region.
Claim 22
Dependent Claim 15 words
The method of claim 13 wherein said absorption spectrum is measured using diffuse reflectance spectroscopy.
Claim 23
Dependent Claim 16 words
The method of claim 20 wherein said absorption spectrum is measured in the near-infrared wavelength region.
Claim 24
Dependent Claim 16 words
The method of claim 20 wherein said absorption spectrum is measured in the visible wavelength region.
Claim 25
Dependent Claim 15 words
The method of claim 13 wherein said multivariate analysis is a partial least squares analysis.
Claim 26
Dependent Claim 17 words
The method of claim 13 wherein a scattering agent is represented in spectra of said calibration set.

References Cited (Backward Citations)

US5190039A Cited
US5231464A Cited
US5517987A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-08-02 2003-02-01 2003-08-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-08-02 2007-02-01 2007-08-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-08-02 2011-02-01 2011-08-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag